ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,384Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 262

$493K Total Retail Price of All Prescriptions

Rank: 21 out of 262

427 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 427 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,472 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 526 476 1 2
LISINOPRIL 445 395 2 3
FUROSEMIDE 441 413 3 4
SIMVASTATIN 423 414 4 1
OMEPRAZOLE 391 358 5 5
METOPROLOL TARTRATE 263 243 6 8
METFORMIN HCL 242 210 7 9
HYDROCHLOROTHIAZIDE 217 197 8 7
DONEPEZIL HCL 205 193 9 23
METOPROLOL SUCCINATE 200 198 10 11
AMLODIPINE BESYLATE 199 196 11 6
CITALOPRAM HBR 191 165 12 20
HYDROCODONE-ACETAMINOPHEN 168 162 S3 13 15
ATORVASTATIN CALCIUM 156 155 14 13
LOVASTATIN 146 134 15 80
MELOXICAM 142 141 16 54
FLUOXETINE HCL 142 128 16 46
DIGOXIN 138 125 18 28
WARFARIN SODIUM 132 121 19 12
GABAPENTIN 128 102 20 19
POTASSIUM CHLORIDE 126 121 21 10
SERTRALINE HCL 125 122 22 14
PREDNISONE 112 112 23 29
ATENOLOL 105 105 24 16
LOSARTAN POTASSIUM 102 102 25 17
CARBIDOPA-LEVODOPA 102 90 25 66
PROPRANOLOL HCL 101 97 27 82
ALENDRONATE SODIUM 94 94 28 21
TRAZODONE HCL 85 75 29 36
NAMENDA 81 81 30 37
FLUTICASONE PROPIONATE 78 70 31 48
QUETIAPINE FUMARATE 74 64 32 71
ISOSORBIDE MONONITRATE ER 72 72 33 33
ADVAIR DISKUS 72 61 33 34
SPIRIVA 72 72 33 61
DIOVAN 67 64 36 47
PRAVASTATIN SODIUM 67 67 36 41
OXYBUTYNIN CHLORIDE 66 66 38 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 50 38 24
PAROXETINE HCL 66 59 38 56
SPIRONOLACTONE 64 56 41 58
TERAZOSIN HCL 63 51 42 126
CLOPIDOGREL 63 63 42 38
DIVALPROEX SODIUM 61 35 44 117
TAMSULOSIN HCL 60 57 45 25
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 45 43
GLYBURIDE 56 56 R 47 89
TRIAMTERENE-HCTZ 55 55 48 32
ROPINIROLE HCL 54 51 49 95
ALLOPURINOL 53 50 50 22
MIRTAZAPINE 53 51 50 35
CIPROFLOXACIN HCL 53 47 50 55
DILTIAZEM ER 52 52 53 75
VENTOLIN HFA 51 51 54 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.